Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.
about
Calpha-H...O = C hydrogen bonds contribute to the specificity of RGD cell-adhesion interactionsStructural investigation of myo-inositol dehydrogenase from Bacillus subtilis: implications for catalytic mechanism and inositol dehydrogenase subfamily classificationMediator kinase inhibition further activates super-enhancer-associated genes in AMLPim kinase inhibitors: a survey of the patent literatureThe structure of dimeric ROCK I reveals the mechanism for ligand selectivityIspE inhibitors identified by a combination of in silico and in vitro high-throughput screeningFrequent side chain methyl carbon-oxygen hydrogen bonding in proteins revealed by computational and stereochemical analysis of neutron structures.Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination.Structure-based virtual screening of glycogen synthase kinase 3β inhibitors: analysis of scoring functions applied to large true actives and decoy sets.Pim-1 ligand-bound structures reveal the mechanism of serine/threonine kinase inhibition by LY294002.Probing molecular docking in a charged model binding site.Binding modes of peptidomimetics designed to inhibit STAT3.Catalytic roles for carbon-oxygen hydrogen bonding in SET domain lysine methyltransferases.Molecular mechanism of serotonin transporter inhibition elucidated by a new flexible docking protocol.Regulation of protein-ligand binding affinity by hydrogen bond pairing.Energy decomposition analysis based on a block-localized wavefunction and multistate density functional theoryProtein kinase inhibitors: contributions from structure to clinical compounds.A medicinal chemist's guide to molecular interactionsFMS Kinase Inhibitors: Current Status and Future Prospects.Receptor-ligand molecular docking.Cl-pi interactions in protein-ligand complexes.Discovery of a Novel Series of CHK1 Kinase Inhibitors with a Distinctive Hinge Binding Mode.Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis.C-H…O hydrogen bonds in FK506-binding protein-ligand interactions.A systematic analysis of atomic protein-ligand interactions in the PDB.Methods of Exploring Protein-Ligand Interactions to Guide Medicinal Chemistry Efforts.ω-Turn: a novel β-turn mimic in globular proteins stabilized by main-chain to side-chain C−H···O interaction.Role of bridging water molecules in GSK3β-inhibitor complexes: insights from QM/MM, MD, and molecular docking studies.Increasing the bioactive space of peptide macrocycles by thioamide substitution.Are 1,4- and 1,5-Disubstituted 1,2,3-Triazoles Good Pharmacophoric Groups?Empirical Scoring Functions for Structure-Based Virtual Screening: Applications, Critical Aspects, and ChallengesA series of lanthanide complexes with different N-donor ligands: synthesis, structures, thermal properties and luminescence behaviorsIdentification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6
P2860
Q24797279-D4441358-51E8-40F8-9C37-CC56042F6EF3Q27664244-EEDCEA53-9498-4906-B47C-99A6331446DAQ28267938-FFAC00A8-9213-429F-9160-D046D3C38FB5Q28271318-6B3A981D-76EB-4B04-A5B6-6D4CB6D4F466Q28279001-53AF5A72-4A74-4E78-9C2E-149365CD7613Q28483059-BD30F0B8-A53C-4F21-8FAD-3FC82393276EQ30368713-C6CDF271-804E-482C-933D-AA1736569505Q33260141-BD42AD86-296C-420A-AAB0-9F0D6E59970DQ33934472-D0CB9894-FDA4-4C69-B1E2-3AA07DEA1139Q34385592-85449B1E-F2AD-4263-ACEF-E0E5ECED32DEQ34516171-13AC74EB-A071-4916-B28C-3A53DD0AA997Q34516992-E07F012B-AC6E-4A06-86AF-84B3C191DFD4Q34522955-740E7608-4B8C-49EF-8285-2AFEF2766472Q35975646-3102E4CA-69CF-4C22-837F-D1A19AF5F521Q36764009-BDDA6549-7055-4A7D-A047-C8B8442E067DQ37037306-21FF4B55-3CE5-4411-9DAE-0E4CBA9989ACQ37417742-6EB0D71C-51F5-49DA-8A5A-E82603E19A60Q37719514-592D7250-FA9F-4F34-A6BA-9519D269D76FQ37995562-A620C3F8-E318-4F33-BB0F-77ED8027E51BQ38783140-570AC4EF-4F4E-438C-BD55-50831F874CF2Q39639555-3857C189-8CC3-43A2-8A4A-519B39A66AFFQ39731432-9786714C-02C2-4025-A27D-70EC02316F33Q40277418-FB61A354-8838-4FA6-8446-A8B221424CAAQ43533831-4079FA87-6D07-423A-BEA9-9640C9E23B4BQ47098164-A937A039-F2BD-4A89-8A7B-9F0FAFCC8FF9Q47348718-7C0FD03B-E0DF-4678-B38E-64E16514A1A1Q53393543-6F33C64C-D689-4751-8F1B-5E1A988C5DE9Q54598455-70E94CFA-619E-41E8-B9D7-2A830495C864Q54941709-D8EA4EA3-BDA1-4951-85F2-0368831E1F50Q57266220-32E511DA-51A5-4076-A89F-CF23ED3752E9Q57492456-C427BA7C-D4B7-4146-994C-4B8513B1BB26Q57523906-E6AD8E54-9F76-47B6-817F-A97DCF6BA0C2Q58098901-C111BB20-D75B-4B71-BCCA-BCBEFCE6EB9C
P2860
Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.
@en
Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.
@nl
type
label
Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.
@en
Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.
@nl
prefLabel
Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.
@en
Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.
@nl
P2093
P2860
P356
P1433
P1476
Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding.
@en
P2093
Albert C Pierce
Guy W Bemis
Kathryn L Sandretto
P2860
P304
P356
10.1002/PROT.10259
P407
P577
2002-12-01T00:00:00Z